BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mahar AL, Compton C, Halabi S, Hess KR, Weiser MR, Groome PA. Personalizing prognosis in colorectal cancer: A systematic review of the quality and nature of clinical prognostic tools for survival outcomes. J Surg Oncol. 2017;116:969-982. [PMID: 28767139 DOI: 10.1002/jso.24774] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 7.2] [Reference Citation Analysis]
Number Citing Articles
1 Cao X, Wang X, Wang H, Xu G, Yu H. Systemic Inflammation Status Relates to Anti-Inflammatory Drug Benefit and Survival in Rectal Cancer. J Surg Res 2021;269:249-59. [PMID: 34624724 DOI: 10.1016/j.jss.2021.08.028] [Reference Citation Analysis]
2 Sun Y, Huang Z, Lin H, Chi P. Prognostic impact of preoperative immunonutritional status in rectal mucinous adenocarcinoma. Future Oncol 2020;16:339-51. [PMID: 32067478 DOI: 10.2217/fon-2019-0793] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Hallet J, Pessaux P, Beyfuss KA, Jayaraman S, Serrano PE, Martel G, Coburn NG, Piardi T, Mahar AL. Critical appraisal of predictive tools to assess the difficulty of laparoscopic liver resection: a systematic review. Surg Endosc 2019;33:366-76. [DOI: 10.1007/s00464-018-6479-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
4 Björkman K, Jalkanen S, Salmi M, Mustonen H, Kaprio T, Kekki H, Pettersson K, Böckelman C, Haglund C. A prognostic model for colorectal cancer based on CEA and a 48-multiplex serum biomarker panel. Sci Rep 2021;11:4287. [PMID: 33619304 DOI: 10.1038/s41598-020-80785-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Chen S, Zhang C, Feng M. Prognostic Value of LncRNA HOTAIR in Colorectal Cancer: A Meta-analysis.Open Med (Wars). 2020;15:76-83. [PMID: 32104724 DOI: 10.1515/med-2020-0012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
6 Iuamoto LR, Meyer A. A commentary on "Construction of a nomogram to predict overall survival for patients with M1 stage of colorectal cancer: A retrospective cohort study" (Int J Surg 2019; Epub ahead of print). Int J Surg 2019;72:241. [PMID: 31770606 DOI: 10.1016/j.ijsu.2019.11.021] [Reference Citation Analysis]
7 Mainenti PP, Stanzione A, Guarino S, Romeo V, Ugga L, Romano F, Storto G, Maurea S, Brunetti A. Colorectal cancer: Parametric evaluation of morphological, functional and molecular tomographic imaging. World J Gastroenterol 2019; 25(35): 5233-5256 [PMID: 31558870 DOI: 10.3748/wjg.v25.i35.5233] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
8 Margonis GA, Andreatos N, Brennan MF. Predicting Survival in Colorectal Liver Metastasis: Time for New Approaches. Ann Surg Oncol 2020;27:4861-3. [DOI: 10.1245/s10434-020-09053-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Cao Y, Deng S, Yan L, Gu J, Mao F, Xue Y, Zheng C, Yang M, Liu H, Liu L, Liu Q, Cai K. An Oxidative Stress Index-Based Score for Prognostic Prediction in Colorectal Cancer Patients Undergoing Surgery. Oxid Med Cell Longev 2021;2021:6693707. [PMID: 33505587 DOI: 10.1155/2021/6693707] [Reference Citation Analysis]
10 Fu X, Zhang Y, Chang L, Hui D, Jia R, Liu N, Zhang H, Han G, Han Z, Li Y, Liu H, Zhu H, Li Q. The JPJDF has Synergistic Effect with Fluoropyrimidine in the Maintenance Therapy for Metastatic Colorectal Cancer. PRA 2020;15:257-69. [DOI: 10.2174/1574892815666200717141205] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Konstantinov AS, Mitin NP, Shelekhova KV. [Assessment of the metastatic potential of localized forms of colorectal cancer]. Arkh Patol 2021;83:5-12. [PMID: 34609798 DOI: 10.17116/patol2021830515] [Reference Citation Analysis]
12 Chen Z, Huang Z, Luo Y, Zou Q, Bai L, Tang G, Wang X, Cao G, Huang M, Xiang J, Yu H. Genome-wide analysis identifies critical DNA methylations within NTRKs genes in colorectal cancer. J Transl Med 2021;19:73. [PMID: 33593392 DOI: 10.1186/s12967-021-02740-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Zou W, Zhao J, Li Y, Wang Z, Yan H, Liu Y, Sun M, Zhuang J, Wang J. Rat Bone Marrow-Derived Mesenchymal Stem Cells Promote the Migration and Invasion of Colorectal Cancer Stem Cells. Onco Targets Ther 2020;13:6617-28. [PMID: 32764957 DOI: 10.2147/OTT.S249353] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Yang C, Zhang Y, Segar N, Huang C, Zeng P, Tan X, Mao L, Chen Z, Haglund F, Larsson O, Chen Z, Lin Y. Nuclear IGF1R interacts with NuMA and regulates 53BP1‑dependent DNA double‑strand break repair in colorectal cancer. Oncol Rep 2021;46:168. [PMID: 34165167 DOI: 10.3892/or.2021.8119] [Reference Citation Analysis]
15 Tham T, Machado R, Herman SW, Kraus D, Costantino P, Roche A. Personalized prognostication in head and neck cancer: A systematic review of nomograms according to the AJCC precision medicine core (PMC) criteria. Head Neck 2019;41:2811-22. [PMID: 31012188 DOI: 10.1002/hed.25778] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
16 Bagante F, Merath K, Squires MH, Weiss M, Alexandrescu S, Marques HP, Aldrighetti L, Maithel SK, Pulitano C, Bauer TW, Shen F, Poultsides GA, Soubrane O, Martel G, Groot Koerkamp B, Guglielmi A, Itaru E, Pawlik TM. The Limitations of Standard Clinicopathologic Features to Accurately Risk-Stratify Prognosis after Resection of Intrahepatic Cholangiocarcinoma. J Gastrointest Surg 2018;22:477-85. [DOI: 10.1007/s11605-018-3682-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
17 Greene FL. The prognosis for prognostic tools. J Surg Oncol 2017;116:983-983. [DOI: 10.1002/jso.24773] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
18 Kamphues C, Andreatos N, Kruppa J, Buettner S, Wang J, Sasaki K, Wagner D, Morioka D, Fitschek F, Løes IM, Imai K, Sun J, Poultsides G, Kaczirek K, Lønning PE, Endo I, Baba H, Kornprat P, Aucejo FN, Wolfgang CL, Kreis ME, Weiss MJ, Margonis GA. The optimal cut-off values for tumor size, number of lesions, and CEA levels in patients with surgically treated colorectal cancer liver metastases: An international, multi-institutional study. J Surg Oncol 2021;123:939-48. [PMID: 33400818 DOI: 10.1002/jso.26361] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Shih Y, Peng C, Chiang P, Shieh M. Dual-Functional Polymeric Micelles Co-Loaded with Antineoplastic Drugs and Tyrosine Kinase Inhibitor for Combination Therapy in Colorectal Cancer. Pharmaceutics 2022;14:768. [DOI: 10.3390/pharmaceutics14040768] [Reference Citation Analysis]
20 Miller S, Bauer S, Schrempf M, Schenkirsch G, Probst A, Märkl B, Martin B. Semiautomatic analysis of tumor proportion in colon cancer: Lessons from a validation study. Pathol Res Pract 2021;227:153634. [PMID: 34628263 DOI: 10.1016/j.prp.2021.153634] [Reference Citation Analysis]
21 Rasmussen JH, Grønhøj C, Håkansson K, Friborg J, Andersen E, Lelkaitis G, Klussmann JP, Wittekindt C, Wagner S, Vogelius IR, von Buchwald C. Risk profiling based on p16 and HPV DNA more accurately predicts location of disease relapse in patients with oropharyngeal squamous cell carcinoma. Ann Oncol 2019;30:629-36. [PMID: 30657857 DOI: 10.1093/annonc/mdz010] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 10.0] [Reference Citation Analysis]
22 Ye C, Xu M, Lin M, Zhang Y, Zheng X, Sun Y, Deng Y, Pan J, Xu Z, Lu X, Chi P. Overexpression of FZD7 is associated with poor survival in patients with colon cancer. Pathology - Research and Practice 2019;215:152478. [DOI: 10.1016/j.prp.2019.152478] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
23 Palazón-Bru A, Mares-García E, López-Bru D, Mares-Arambul E, Gil-Guillén VF, Carbonell-Torregrosa MÁ. A systematic review of predictive models for recurrence and mortality in patients with tongue cancer. Eur J Cancer Care (Engl) 2019;28:e13157. [PMID: 31441567 DOI: 10.1111/ecc.13157] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
24 Weiser MR, Hsu M, Bauer PS, Chapman WC Jr, González IA, Chatterjee D, Lingam D, Mutch MG, Keshinro A, Shia J, Vakiani E, Konishi T, Shimada Y, Stadler Z, Segal NH, Cercek A, Saltz L, Yaeger R, Varghese A, Widmar M, Wei IH, Pappou EP, Smith JJ, Nash G, Paty P, Garcia-Aguilar J, Gonen M. Clinical Calculator Based on Molecular and Clinicopathologic Characteristics Predicts Recurrence Following Resection of Stage I-III Colon Cancer. J Clin Oncol 2021;39:911-9. [PMID: 33439688 DOI: 10.1200/JCO.20.02553] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
25 Bennett S, Søreide K, Gholami S, Pessaux P, Teh C, Segelov E, Kennecke H, Prenen H, Myrehaug S, Callegaro D, Hallet J. Strategies for the delay of surgery in the management of resectable hepatobiliary malignancies during the COVID-19 pandemic. Curr Oncol 2020;27:e501-11. [PMID: 33173390 DOI: 10.3747/co.27.6785] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
26 Liu L, Yan X, Wu D, Yang Y, Li M, Su Y, Yang W, Shan Z, Gao Y, Jin Z. High expression of Ras-related protein 1A promotes an aggressive phenotype in colorectal cancer via PTEN/FOXO3/CCND1 pathway. J Exp Clin Cancer Res 2018;37:178. [PMID: 30064475 DOI: 10.1186/s13046-018-0827-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
27 Silva RMSD, Collaço PMC, Cunha KS, Dias EP. Diagnosis of Advanced Disease in Cases of Colorectal Cancer in a Developing Country. Journal of Coloproctology. [DOI: 10.1055/s-0041-1736517] [Reference Citation Analysis]
28 Luvián-Morales J, González-Trejo S, Carrillo JF, Herrera-Goepfert R, Aiello-Crocifoglio V, Gallardo-Rincón D, Ochoa-Carrillo FJ, Oñate-Ocaña LF. Association of the prognostic nutritional index and overall survival in patients with colorectal cancer: A STROBE compliant retrospective cohort study. Cancer Med 2019;8:3379-88. [PMID: 31069966 DOI: 10.1002/cam4.2212] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
29 Liang X, Wang Z, Dai Z, Zhang H, Cheng Q, Liu Z. Promoting Prognostic Model Application: A Review Based on Gliomas. J Oncol 2021;2021:7840007. [PMID: 34394352 DOI: 10.1155/2021/7840007] [Reference Citation Analysis]
30 Hong T, Cai D, Jin L, Zhang Y, Lu T, Hua D, Wu X. Development and validation of a nomogram to predict survival after curative resection of nonmetastatic colorectal cancer. Cancer Med 2020;9:4126-36. [PMID: 32314876 DOI: 10.1002/cam4.3010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
31 Gupta V, Coburn N, Kidane B, Hess KR, Compton C, Ringash J, Darling G, Mahar AL. Survival prediction tools for esophageal and gastroesophageal junction cancer: A systematic review. J Thorac Cardiovasc Surg. 2018;156:847-856. [PMID: 30011772 DOI: 10.1016/j.jtcvs.2018.03.146] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
32 Sun T, Zhang G, Ning T, Chen Q, Chu Y, Luo Y, You H, Su B, Li C, Guo Q, Jiang C. A Versatile Theranostic Platform for Colorectal Cancer Peritoneal Metastases: Real-Time Tumor-Tracking and Photothermal-Enhanced Chemotherapy. Adv Sci (Weinh) 2021;:e2102256. [PMID: 34398516 DOI: 10.1002/advs.202102256] [Reference Citation Analysis]
33 Mir ZM, Golding H, McKeown S, Nanji S, Flemming JA, Groome PA. Appraisal of multivariable prognostic models for post-operative liver decompensation following partial hepatectomy: a systematic review. HPB (Oxford) 2021:S1365-182X(21)00612-2. [PMID: 34332894 DOI: 10.1016/j.hpb.2021.06.430] [Reference Citation Analysis]
34 Luo Z, Fu Z, Li T, Zhang Y, Zhang J, Yang Y, Yang Z, Li Q, Qiu Z, Huang C. Development and Validation of the Individualized Prognostic Nomograms in Patients With Right- and Left-Sided Colon Cancer. Front Oncol 2021;11:709835. [PMID: 34790565 DOI: 10.3389/fonc.2021.709835] [Reference Citation Analysis]
35 Zhang G, Gao Y, Yu Z, Su H. Upregulated long intergenic non-protein coding RNA 1094 (LINC01094) is linked to poor prognosis and alteration of cell function in colorectal cancer. Bioengineered 2022. [PMID: 35287563 DOI: 10.1080/21655979.2022.2051839] [Reference Citation Analysis]
36 Xie W, Zhang Y, Wang B, Hu Y, Zhan B, Wei F, Tang J, Lian J. Tripartite motif containing 24 regulates cell proliferation in colorectal cancer through YAP signaling. Cancer Med 2020;9:6367-76. [PMID: 32677374 DOI: 10.1002/cam4.3310] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
37 Cheng E, Ou FS, Ma C, Spiegelman D, Zhang S, Zhou X, Bainter TM, Saltz LB, Niedzwiecki D, Mayer RJ, Whittom R, Hantel A, Benson A, Atienza D, Messino M, Kindler H, Giovannucci EL, Van Blarigan EL, Brown JC, Ng K, Gross CP, Meyerhardt JA, Fuchs CS. Diet- and Lifestyle-Based Prediction Models to Estimate Cancer Recurrence and Death in Patients With Stage III Colon Cancer (CALGB 89803/Alliance). J Clin Oncol 2022;40:740-51. [PMID: 34995084 DOI: 10.1200/JCO.21.01784] [Reference Citation Analysis]
38 Roos A, Byron SA. Genomics-Enabled Precision Medicine for Cancer. Cancer Treat Res 2019;178:137-69. [PMID: 31209844 DOI: 10.1007/978-3-030-16391-4_5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
39 Konishi T, Shimada Y, Hsu M, Wei IH, Pappou E, Smith JJ, Nash GM, Guillem JG, Paty PB, Garcia-Aguilar J, Cercek A, Yaeger R, Stadler ZK, Segal NH, Varghese A, Saltz LB, Shia J, Vakiani E, Gönen M, Weiser MR. Contemporary Validation of a Nomogram Predicting Colon Cancer Recurrence, Revealing All-Stage Improved Outcomes. JNCI Cancer Spectr 2019;3:pkz015. [PMID: 31119207 DOI: 10.1093/jncics/pkz015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
40 Deng Y, Zheng X, Zhang Y, Xu M, Ye C, Lin M, Pan J, Xu Z, Lu X, Chi P. High SPRR1A expression is associated with poor survival in patients with colon cancer. Oncol Lett 2020;19:3417-24. [PMID: 32269614 DOI: 10.3892/ol.2020.11453] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
41 Weiser MR, Chou JF, Keshinro A, Chapman WC Jr, Bauer PS, Mutch MG, Parikh PJ, Cercek A, Saltz LB, Gollub MJ, Romesser PB, Crane CH, Shia J, Markowitz AJ, Garcia-Aguilar J, Gönen M; Colorectal Cancer Disease Management Team of Memorial Sloan Kettering Cancer Center. Development and Assessment of a Clinical Calculator for Estimating the Likelihood of Recurrence and Survival Among Patients With Locally Advanced Rectal Cancer Treated With Chemotherapy, Radiotherapy, and Surgery. JAMA Netw Open 2021;4:e2133457. [PMID: 34748003 DOI: 10.1001/jamanetworkopen.2021.33457] [Reference Citation Analysis]
42 Palazón‐bru A, Mares‐garcía E, López‐bru D, Mares‐arambul E, Folgado‐de la Rosa DM, Carbonell‐torregrosa MDLÁ, Gil‐guillén VF. A critical appraisal of the clinical applicability and risk of bias of the predictive models for mortality and recurrence in patients with oropharyngeal cancer: Systematic review. Head & Neck 2020;42:763-73. [DOI: 10.1002/hed.26025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
43 Mulens-Arias V, Nicolás-Boluda A, Pinto A, Balfourier A, Carn F, Silva AKA, Pocard M, Gazeau F. Tumor-Selective Immune-Active Mild Hyperthermia Associated with Chemotherapy in Colon Peritoneal Metastasis by Photoactivation of Fluorouracil-Gold Nanoparticle Complexes. ACS Nano 2021;15:3330-48. [PMID: 33528985 DOI: 10.1021/acsnano.0c10276] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
44 Grenda TR, Chang AC. Prognostic tools for esophageal cancer: "Looking for the crystal ball". J Thorac Cardiovasc Surg 2018;156:857-8. [PMID: 29779638 DOI: 10.1016/j.jtcvs.2018.04.029] [Reference Citation Analysis]